MSD Australia and New Zealand Revenue and Competitors
Estimated Revenue & Valuation
- MSD Australia and New Zealand's estimated annual revenue is currently $90.5M per year.
- MSD Australia and New Zealand's estimated revenue per employee is $201,000
Employee Data
- MSD Australia and New Zealand has 450 Employees.
- MSD Australia and New Zealand grew their employee count by 5% last year.
MSD Australia and New Zealand's People
Name | Title | Email/Phone |
---|
MSD Australia and New Zealand Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $62.9M | 313 | 8% | N/A | N/A |
#2 | $26.5M | 132 | 7% | N/A | N/A |
#3 | $20.5M | 102 | 0% | N/A | N/A |
#4 | $18.3M | 91 | 6% | N/A | N/A |
#5 | $18.7M | 93 | 2% | N/A | N/A |
#6 | $72.2M | 359 | 6% | N/A | N/A |
#7 | $55.3M | 275 | 6% | N/A | N/A |
#8 | $35.8M | 178 | 6% | N/A | N/A |
#9 | $31M | 154 | 4% | N/A | N/A |
#10 | $70.8M | 352 | 5% | N/A | N/A |
What Is MSD Australia and New Zealand?
Today's MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. In Australia, our headquarters are in Sydney, and Auckland for New Zealand. Today's MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information about MSD in Australia, visit www.msd-australia.com.au. For more information about MSD in New Zealand http://www.msd-newzealand.com. You can also connect with us on Twitter, Facebook and YouTube. Prescription medicines, Over the counter medicines, Animal Health medicines
keywords:N/AN/A
Total Funding
450
Number of Employees
$90.5M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MSD Australia and New Zealand News
Former India pacer wants Dhoni to return for T20 World Cup in Australia ... friends has tweeted his desire to see MSD come out of retirement...
Australia's patent term extension (PTE) provisions are rarely out of the ... MSD v Sandoz PTE must be based on the earliest listed product...
The Full Court decisions in MSD v Sandoz and Ono, and the APO's decision in Bayer, demonstrate the challenges pharmaceutical patentees face in...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35M | 461 | N/A | N/A |
#2 | $111.4M | 495 | N/A | N/A |
#3 | $92.3M | 509 | N/A | N/A |
#4 | $140.7M | 549 | N/A | N/A |
#5 | $188M | 614 | 4% | N/A |